Verve Therapeutics Inc.

In News

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - investor.lilly.com

investor.lilly.com - Jun 17, 2025

In Vivo Gene Editing Market (2026-2035) | Genetic Engineering, - openPR.com

openPR.com - May 11, 2026

Eli Lilly acquires Verve Therapeutics in $1.3 billion deal, validating gene editing for heart disease - drugdiscoverytrends.com

drugdiscoverytrends.com - Jul 19, 2025

Verve Therapeutics, Inc. (VERV): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Jul 10, 2025

Lilly and Verve announce expiration of Verve tender offer - PR Newswire

PR Newswire - Jul 24, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics - TMX Newsfile

TMX Newsfile - May 04, 2026

Eli Lilly to Acquire Verve Therapeutics to Advance One-Time Cardiovascular Treatments - CRISPR Medicine News

CRISPR Medicine News - Jun 17, 2025

Lilly to acquire Verve Therapeutics for $1.3 billion - C&EN

C&EN - Jun 18, 2025

Lilly to Acquire Verve Therapeutics in $1.3B Deal Targeting One-Time Gene-Editing Treatments for Cardiovascular Disease - BioPharm International

BioPharm International - Jun 17, 2025

Lilly to Acquire Verve Therapeutics for Up to $1.3B - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Jun 17, 2025

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion - WSJ

WSJ - Jun 17, 2025

Lilly to acquire Verve in $1B bet on gene editing for heart disease - BioPharma Dive

BioPharma Dive - Jun 17, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment